New Study Reports Key Findings for the ABThera™ Open Abdomen Negative Pressure Therapy System
May 17, 2013

Kinetic Concepts, Inc. announced today that ABThera™ Open Abdomen Negative Pressure Therapy System (ABThera™ OA NPT) was associated with significantly improved patient outcomes compared to traditional Barker’s vacuum-packing technique (BVPT) in trauma and surgical patients studied. Results of the observational study, “Prospective Study Examining Clinical Outcomes Associated with a Negative Pressure Wound Therapy System and Barker’s Vacuum Packing Technique” were published in"......

Quintiles Announces Completion of Initial Public Offering of 27,236,841 Shares of Common Stock
May 17, 2013

Quintiles today announced the completion of its initial public offering of 27,236,841 shares of its common stock at a price to the public of $40.00 per share. Quintiles offered and sold 13,125,000 shares of common stock in the offering and selling shareholders offered and sold 14,111,841 shares of common stock in the offering, including 3,552,631 shares that were offered and sold by the selling shareholders pursuant to the full exercise of the underwriters’"...

ASCO 2013: New Phase III data reveal targeted treatment with afatinib* or with nintedanib* improves progression-free survival in patients with advanced NSCLC
May 16, 2013

Growing body of clinical data supports superiority of the irreversible ErbB Family Blocker afatinib* over standard chemotherapy (with combination of cisplatin and gemcitabine or pemetrexed) for first-line treatment of patients with EGFR-mutation positive advanced NSCLC

First set of Phase III results unveiled from"...

Merck Serono and Quintiles Announce Innovative Clinical Development Partnership
May 16, 2013

Merck Serono, a division of Merck, Darmstadt, Germany, and Quintiles, the world’s largest provider of biopharmaceutical development and commercial outsourcing services, today announced a new, five-year clinical development agreement. This strategic collaboration is the first-of-its-kind between a biopharmaceutical company and a biopharmaceutical services provider, creating a comprehensive process that integrates the expertise and experience from both organizations into a single, well-aligned clinical development engine.

...

New evidence establishes EPA as highly predictive of skin graft failure and supports the utility of Systagenix WOUNDCHEK™ Protease Status point of care test in this application
May 15, 2013

New evidence presented on Wednesday 15th May 2013 at the European Wound Management Association (EWMA)’s conference in Copenhagen, revealed that elevated protease activity (EPA) was detected in almost half the wounds (43%) that resulted in skin graft failure1.

......

Al Nahdi Medical attracts 5,000 participants and supports Sanad Children's Cancer Support Association with SR250,000
May 13, 2013

The campaign's aim was for members of the public to take images next to Nahdi's logo carrying a unique chosen message to the children of Sanad Association and upload it on the various social media channels. At the end of the campaign, that witnessed enormous participation from the public, 5000 images were uploaded and Al Nahdi Medical Company donated SR50 per picture.

The announcement of the campaign results came as part of a celebration organized by Al Nahdi Medical Company at Sanad's headquarters in Riyadh in the presence of...

Lincor Solutions Launches World’s First Mobile Solution for Patient Engagement and Clinical Services
May 13, 2013

Lincor Solutions Launches World’s First Mobile Solution for Patient Engagement and Clinical Services

MEDIVista MOBILE delivers services to Apple iPad and Android devices

eHealth Week

Lincor announces the latest addition to the MEDIVista product suite – MEDIVista MOBILE, during eHealth Week in Dublin.

Coca-Cola Announces Global Commitments to Help Fight Obesity
May 9, 2013

The Coca-Cola Company today announces four global business commitments to further contribute to healthier, happier, and more active communities. These commitments, which apply to the more than 200 countries where we do business, are to:

1) Offer low- or no- calorie beverage options in every market

2) Provide transparent"...

Quintiles Announces Pricing of Initial Public Offering
May 9, 2013

Quintiles today announced the pricing of its initial public offering of 23,684,210 shares of its common stock at a price to the public of $40.00 per share. The shares of Quintiles common stock are expected to begin trading on the New York Stock Exchange under the single-letter symbol "Q” on May 9, 2013.

Quintiles"...

Philips, Al Faisaliah Medical Systems officially open Philips Healthcare Saudi Arabia
May 9, 2013

The partnership marks an important milestone in Philips and FMS' mutual commitment to raise the standards of healthcare in the country.

Deborah DiSanzo, Chief Executive Officer, Philips Healthcare and HRH Mohammed bin Khaled Al Abdullah Al Faisal, President and Chief Executive Officer of the Al Faisaliah Group commemorated the launch at a ribbon cutting ceremony in Riyadh. Following the signing of the agreement in September 2012, by Frans van Houten, Chief Executive Officer, Royal Philips and HRH Mohammed bin Khaled Al Abdullah...